FDA Shares is Latest Thinking on Oncology Trial Eligibility

Drug Industry Daily
A A
The FDA on Tuesday issued five guidance documents—including one final guidance—that the agency hopes will help sponsors get a handle on increasingly complex cancer trials.

To View This Article:

Login

Subscribe To Drug Industry Daily